Effects of caffeine on intraocular pressure are subject to tolerance: a comparative study between low and high caffeine consumers
Background Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown. Methods In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy i...
Saved in:
| Published in | Psychopharmacology Vol. 236; no. 2; pp. 811 - 819 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.02.2019
Springer Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0033-3158 1432-2072 1432-2072 |
| DOI | 10.1007/s00213-018-5114-2 |
Cover
Loading…
| Abstract | Background
Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown.
Methods
In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (
n
= 21) and high (
n
= 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained.
Results
Caffeine induced an acute IOP rise (
p
< 0.001,
ƞ
p
2
= 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (
p
= 0.002,
ƞ
p
2
= 0.222); however, similar responses were given by high- and low-caffeine consumers (
p
= 0.256). Our data did not reveal any effect of caffeine consumption on OPP (
p
= 0.304).
Conclusions
These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. |
|---|---|
| AbstractList | Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown. In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained. Caffeine induced an acute IOP rise (p < 0.001, Æ.sub.p.sup.2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, Æ.sub.p.sup.2 = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304). These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown. In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained. Caffeine induced an acute IOP rise (p < 0.001, ƞ = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, ƞ = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304). These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown.BACKGROUNDCaffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown.In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained.METHODSIn this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained.Caffeine induced an acute IOP rise (p < 0.001, ƞp2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, ƞp2 = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304).RESULTSCaffeine induced an acute IOP rise (p < 0.001, ƞp2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, ƞp2 = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304).These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma.CONCLUSIONSThese results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. Background Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown. Methods In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained. Results Caffeine induced an acute IOP rise (p < 0.001, Æ.sub.p.sup.2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, Æ.sub.p.sup.2 = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304). Conclusions These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. Background Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown. Methods In this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- ( n = 21) and high ( n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained. Results Caffeine induced an acute IOP rise ( p < 0.001, ƞ p 2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo ( p = 0.002, ƞ p 2 = 0.222); however, similar responses were given by high- and low-caffeine consumers ( p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP ( p = 0.304). Conclusions These results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. BackgroundCaffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and high-caffeine consumers remain unknown.MethodsIn this placebo-controlled, double-blind, and balanced crossover study, 40 healthy individuals were divided in low- (n = 21) and high (n = 19)-caffeine consumers, according to their daily caffeine consumption. All participants ingested either caffeine (4 mg/kg) or placebo, and IOP and OPP were measured after 30, 60, and 90 min of ingesting caffeine or placebo. Subjective feelings of arousal were also obtained.ResultsCaffeine induced an acute IOP rise (p < 0.001, ƞp2 = 0.408), whereas habitual caffeine demonstrated a mediating effect on the IOP changes induced by caffeine intake, with high-caffeine consumers showing a less accentuated IOP rise in comparison to low-caffeine consumers. The greatest IOP change induced by caffeine intake was reached after 90 min from capsule ingestion, being more accentuated for the low-caffeine consumers (+ 3.4 mmHg) than for the high-caffeine consumers (+ 1.2 mmHg). Consequently, the participants reported higher levels of perceived arousal after ingesting caffeine in comparison to placebo (p = 0.002, ƞp2 = 0.222); however, similar responses were given by high- and low-caffeine consumers (p = 0.256). Our data did not reveal any effect of caffeine consumption on OPP (p = 0.304).ConclusionsThese results suggest that IOP responsiveness to caffeine ingestion is subject to tolerance, which could have important implication in the management of glaucoma. This finding may be due to alterations in the adenosine receptor system caused by chronic caffeine consumption. Future studies are needed to assess if these findings are also applicable to patients with glaucoma. |
| Audience | Academic |
| Author | Redondo, Beatríz Bermúdez, Javier Molina, Rubén Vera, Jesús Jiménez, Raimundo |
| Author_xml | – sequence: 1 givenname: Jesús surname: Vera fullname: Vera, Jesús organization: Department of Optics, Faculty of Sciences, University of Granada – sequence: 2 givenname: Beatríz orcidid: 0000-0003-4571-873X surname: Redondo fullname: Redondo, Beatríz email: beadondo@correo.ugr.es organization: Department of Optics, Faculty of Sciences, University of Granada – sequence: 3 givenname: Rubén surname: Molina fullname: Molina, Rubén organization: Department of Optics, Faculty of Sciences, University of Granada – sequence: 4 givenname: Javier surname: Bermúdez fullname: Bermúdez, Javier organization: Department of Optics, Faculty of Sciences, University of Granada – sequence: 5 givenname: Raimundo surname: Jiménez fullname: Jiménez, Raimundo organization: Department of Optics, Faculty of Sciences, University of Granada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30417232$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1rFTEUhoNU7G31B7iRgBs3U_M9M-5KqR9QcKPrkMmc3OYyk1yTjKVL_7kZbsvFouaDhPC854T3nDN0EmIAhF5TckEJad9nQhjlDaFdIykVDXuGNlRw1jDSshO0IYTzhlPZnaKznHekDtGJF-iUE0FbxtkG_bp2DmzJODpsTb37ADgG7ENJJtplMgnvE-S8JMCm7rwMuyrAJdY1QTLBwgdssI3z3iRT_M_KlGW8xwOUO4CAp3iHTRjxrd_eHnPYGPIyQ8ov0XNnpgyvHs5z9P3j9berz83N109fri5vGit4XxrgjCnFHB94J0UvR6GEoqLtBzW0woBQwyipZCMbFQxSDEIK6Zw0VMpeiZGfo3eHuPsUfyyQi559tjBNJkBcsq5OMiZ61smKvn2C7uKSQv3dStFWUCbFkdqaCbQPLlbL7BpUX8q2ZYpzRSt18ReqzhFmX00A5-v7H4I3D8mXYYZR75OfTbrXjzWrQHsAbIo5J3Da-lKNj2vJ_KQp0Wt36EN36Nodeu0OvSrpE-Vj8P9p2EGTKxu2kI5e_Fv0G0tVyXo |
| CitedBy_id | crossref_primary_10_1016_j_heliyon_2020_e04408 crossref_primary_10_1177_1120672120960337 crossref_primary_10_1007_s10571_021_01077_4 crossref_primary_10_1080_08164622_2022_2054315 crossref_primary_10_1123_ijsnem_2024_0051 crossref_primary_10_3390_nu14030534 crossref_primary_10_1186_s12967_022_03822_9 crossref_primary_10_1080_15438627_2022_2079987 crossref_primary_10_1016_j_mam_2023_101203 crossref_primary_10_1080_10408398_2022_2074362 crossref_primary_10_1016_j_optom_2021_06_005 crossref_primary_10_1007_s00417_019_04556_z crossref_primary_10_3390_nu16020207 crossref_primary_10_1007_s00417_020_04736_2 crossref_primary_10_1186_s40246_024_00637_1 crossref_primary_10_1080_08164622_2021_1935218 crossref_primary_10_1007_s00394_019_02167_2 crossref_primary_10_1016_j_ophtha_2022_04_027 crossref_primary_10_1111_ceo_13755 crossref_primary_10_1007_s00417_024_06565_z crossref_primary_10_1016_j_ophtha_2020_12_009 crossref_primary_10_1016_j_exer_2019_05_003 crossref_primary_10_1097_IJG_0000000000001510 crossref_primary_10_1007_s00417_020_04835_0 crossref_primary_10_1016_j_survophthal_2021_09_002 crossref_primary_10_4103_ijo_IJO_1845_21 crossref_primary_10_3390_molecules27020448 crossref_primary_10_1167_iovs_65_11_10 |
| Cites_doi | 10.1007/s00213-004-2104-3 10.1097/00061198-200102000-00006 10.1111/aos.12298 10.1016/S0021-5155(01)00498-1 10.1016/j.survophthal.2012.05.003 10.1167/iovs.07-1425 10.1146/annurev-nutr-071816-064941 10.1007/s10654-016-0202-2 10.3109/15569527.2015.1104330 10.1007/s002130100841 10.1097/ICU.0b013e32831eef82 10.1345/aph.1K337 10.1161/01.CIR.0000046228.97025.3A 10.1111/j.1471-4159.2007.05196.x 10.1097/IJG.0b013e318133fb32 10.1016/j.nut.2010.08.004 10.1345/aph.1A279 10.1007/s00213-012-2917-4 10.1016/j.biopsycho.2010.12.010 10.1111/aos.12408 10.1111/j.1755-3768.2012.02486.x 10.1097/IAE.0000000000000043 10.1097/01.ijg.0000184832.08783.be 10.1016/j.exer.2010.09.002 10.1038/eye.2016.288 10.1152/japplphysiol.00898.2013 10.1097/OPX.0000000000000129 10.1007/s00421-016-3496-6 10.1016/j.ophtha.2015.11.031 10.1016/j.neuroimage.2009.03.012 10.1046/j.1365-2125.2002.01681.x 10.1016/S0091-3057(00)00192-1 10.1007/s00417-010-1455-1 10.1016/0278-6915(95)00093-3 10.1007/s00213-017-4638-1 10.1016/j.coph.2012.09.003 10.1001/jamaophthalmol.2018.1746 10.1007/s00417-018-4030-9 10.1016/0165-0173(92)90012-B 10.1001/archophthalmol.2011.72 10.1155/2010/834060 10.1161/01.CIR.100.4.354 10.1038/sj.ejcn.1600899 10.1016/j.ophtha.2014.05.013 10.1038/eye.2012.113 10.1007/s00213-006-0341-3 10.2174/1381612823666170215144649 10.1001/jamainternmed.2018.2425 10.1097/00126097-200402000-00007 10.1007/s00394-017-1591-z 10.1016/S0140-6736(78)92998-7 10.1111/opo.12009 10.1016/j.ophtha.2005.01.042 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag GmbH Germany, part of Springer Nature 2018 COPYRIGHT 2019 Springer Psychopharmacology is a copyright of Springer, (2018). All Rights Reserved. |
| Copyright_xml | – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2018 – notice: COPYRIGHT 2019 Springer – notice: Psychopharmacology is a copyright of Springer, (2018). All Rights Reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QR 7RV 7TK 7X7 7XB 88E 88G 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ K9. KB0 M0S M1P M2M NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
| DOI | 10.1007/s00213-018-5114-2 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Psychology Database ProQuest Nursing and Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Animal Behavior Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Psychology |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1432-2072 |
| EndPage | 819 |
| ExternalDocumentID | A577263361 30417232 10_1007_s00213_018_5114_2 |
| Genre | Journal Article Comparative Study |
| GroupedDBID | -4W -BR 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS RHV SBY SOJ ~EX .55 3SX AAYXX CITATION KOW N2Q R9- X7M --- -56 -5G -EM -Y2 -~C .86 .GJ .VR 04C 06C 06D 0R~ 0VY 123 199 1N0 1SB 2.D 203 28- 29P 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2QV 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 53G 5QI 5RE 5VS 67N 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTAH ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPIV ACPRK ACUHS ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. B0M BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF DDRTE DL5 DNIVK DPUIP DU5 DWQXO DXH EAD EAP EBC EBD EBLON EBS ECM EIF EIHBH EIOEI EJD EMB EMK EMOBN EN4 EPAXT EPL EPS ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO ICJ IHE IHR IJ- IKXTQ IMOTQ INH INR IPY ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M2M M4Y MA- MK0 N9A NAPCQ NB0 NDZJH NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P PF- PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TN5 TSG TSK TSV TUC TUS U2A U9L UAP UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WIP WJK WK6 WK8 WOW XOL YLTOR YQJ YYP Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZGI ZMTXR ZOVNA ZY4 ~8M 7QG 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 AAPKM ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA |
| ID | FETCH-LOGICAL-c439t-e322662f3b385495d46461479b6b74ae46bd5152d2d6eb54b4545ff5a155964d3 |
| IEDL.DBID | 7X7 |
| ISSN | 0033-3158 1432-2072 |
| IngestDate | Fri Jul 11 07:05:41 EDT 2025 Sat Aug 16 15:32:31 EDT 2025 Wed Mar 19 00:49:02 EDT 2025 Sat Mar 08 18:38:08 EST 2025 Wed Feb 19 02:36:21 EST 2025 Thu Apr 24 22:57:28 EDT 2025 Tue Jul 01 04:16:54 EDT 2025 Fri Feb 21 02:34:07 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Ocular perfusion pressure Caffeine Intraocular pressure |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c439t-e322662f3b385495d46461479b6b74ae46bd5152d2d6eb54b4545ff5a155964d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| ORCID | 0000-0003-4571-873X |
| PMID | 30417232 |
| PQID | 2131741254 |
| PQPubID | 47309 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_2132249285 proquest_journals_2131741254 gale_infotracmisc_A577263361 gale_infotracacademiconefile_A577263361 pubmed_primary_30417232 crossref_citationtrail_10_1007_s00213_018_5114_2 crossref_primary_10_1007_s00213_018_5114_2 springer_journals_10_1007_s00213_018_5114_2 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-02-01 |
| PublicationDateYYYYMMDD | 2019-02-01 |
| PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Psychopharmacology |
| PublicationTitleAbbrev | Psychopharmacology |
| PublicationTitleAlternate | Psychopharmacology (Berl) |
| PublicationYear | 2019 |
| Publisher | Springer Berlin Heidelberg Springer Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer – name: Springer Nature B.V |
| References | Agnifili, Mastropasqua, Frezzotti, Fasanella, Motolese, Pedrotti, Iorio, Mattei, Motolese, Mastropasqua (CR2) 2015; 93 Cherecheanu, Garhofer, Schmidl, Werkmeister, Schmetterer (CR10) 2013; 13 Jiwani, Rhee, Brauner, Gardiner, Chen, Shen, Chen, Grosskreutz, Chang, Kloek, Greenstein, Borboli-Gerogiannis, Pasquale, Chaudhry, Loomis, Wiggs, Pasquale, Turalba (CR31) 2012; 26 Haskell, Kennedy, Wesnes, Scholey (CR28) 2005; 179 Kang, Willet, Rosner (CR32) 2008; 49 Osei, Ovenseri-Ogbomo, Kyei, Ntodie (CR44) 2014; 91 Chandrasekaran, Rochtchina, Mitchell (CR8) 2005; 14 Ismail, Bhatti, Faye, Lu, Laude, Tang (CR30) 2018; 256 Childs, De Wit (CR11) 2006; 185 De Moraes, Juthani, Liebmann (CR17) 2011; 129 Echeverri, Montes, Cabrera, Galán, Prieto (CR21) 2010; 2010 Grosso, Micek, Godos, Sciacca, Pajak, Martínez-González, Giovannucci, Galvano (CR26) 2016; 31 Glade (CR25) 2010; 26 Terai, Spoerl, Pillunat, Stodtmeister (CR51) 2012; 90 Mort, Kruse (CR39) 2008; 42 CR4 de Morree, Klein, Marcora (CR19) 2014; 117 Nurminen, Niittynen, Korpela, Vapaatalo (CR42) 1999; 53 De Moraes, Mansouri, Liebmann, Ritch (CR18) 2018; 10022 Loftfield, Cornelis, Caporaso (CR36) 2018; 178 Einöther, Giesbrecht (CR22) 2013; 225 Li, Wang, Guo, Wang, Sun (CR35) 2011; 249 Cuckson, Moran, Seed, Reinders, Shennan (CR15) 2004; 9 CR40 Vural, Kara, Sayin, Pirhan, Ersan (CR54) 2014; 34 Barone, Roberts (CR6) 1996; 34 Pakrou, Gray, Mills, Landers, Craig (CR45) 2008; 17 Ferré (CR23) 2008; 105 Watson, Deary, Kerr (CR55) 2002; 54 Mikalsen, Bertelsen, Flaten (CR37) 2001; 157 Schmidl, Garhofer, Schmetterer (CR49) 2011; 93 Ajayi, Ukwade (CR3) 2001; 10 Rysz, Franczyk, Banach, Gluba-Brzozka (CR48) 2017; 23 Chan, Grossi, Khawaja, Yip, Khaw, Patel, Khaw, Morgan, Vernon, Foster (CR7) 2016; 123 Tham, Li, Wong, Quigley, Aung, Cheng (CR52) 2014; 121 Corti, Binggeli, Sudano, Spieker, Hänseler, Ruschitzka, Chaplin, Lüscher, Noll (CR13) 2002; 106 Leske (CR34) 2009; 20 Avisar, Avisar, Weinberger (CR5) 2002; 36 Smirmaul, de Moraes, Angius, Marcora (CR50) 2016; 117 CR53 Grosso, Godos, Galvano, Giovannucci (CR27) 2017; 37 Abokyi, Owusu-Mensah, Osei (CR1) 2016; 31 Costa, Harris, Anderson, Stodtmeister, Cremasco, Kergoat, Lovasik, Stalmans, Zeitz, Lanzl, Gugleta, Schmetterer (CR14) 2014; 92 Nehlig, Daval, Debry (CR41) 1992; 17 Okuno, Sugiyama, Tominaga, Kojima, Ikeda (CR43) 2002; 46 Quaranta, Katsanos, Russo, Riva (CR46) 2013; 58 Franklin, Khan, Wong, Larson, Levy (CR24) 1999; 100 Kennedy, Haskell (CR33) 2011; 86 Quinlan, Lane, Moore, Aspen, Rycroft, O’Brien (CR47) 2000; 66 Millar-Craig, Bishop, Raftery (CR38) 1978; 311 Connell, Thompson, Turuwhenua, Hess, Gant (CR12) 2017; 234 D’Elia, la Fata, Galletti, Scalfi, Strazzullo (CR16) 2017; 0 Chen, Parrish (CR9) 2009; 46 Hoddes, Zarcone, Dement (CR29) 1972; 9 Dervişoğulları, Totan, Yüce, Kulak (CR20) 2016; 35 D Echeverri (5114_CR21) 2010; 2010 J Kang (5114_CR32) 2008; 49 A Ismail (5114_CR30) 2018; 256 J Watson (5114_CR55) 2002; 54 E Loftfield (5114_CR36) 2018; 178 CG Moraes De (5114_CR18) 2018; 10022 A Mikalsen (5114_CR37) 2001; 157 T Okuno (5114_CR43) 2002; 46 SS Franklin (5114_CR24) 1999; 100 M Li (5114_CR35) 2011; 249 5114_CR53 G Grosso (5114_CR27) 2017; 37 AZ Jiwani (5114_CR31) 2012; 26 MS Dervişoğulları (5114_CR20) 2016; 35 MJ Glade (5114_CR25) 2010; 26 S Chandrasekaran (5114_CR8) 2005; 14 L D’Elia (5114_CR16) 2017; 0 BPC Smirmaul (5114_CR50) 2016; 117 CJW Connell (5114_CR12) 2017; 234 PT Quinlan (5114_CR47) 2000; 66 E Hoddes (5114_CR29) 1972; 9 KA Osei (5114_CR44) 2014; 91 AD Vural (5114_CR54) 2014; 34 5114_CR40 S Abokyi (5114_CR1) 2016; 31 L Agnifili (5114_CR2) 2015; 93 AP Cherecheanu (5114_CR10) 2013; 13 MW Millar-Craig (5114_CR38) 1978; 311 A Nehlig (5114_CR41) 1992; 17 JR Mort (5114_CR39) 2008; 42 VP Costa (5114_CR14) 2014; 92 HM Morree de (5114_CR19) 2014; 117 D Schmidl (5114_CR49) 2011; 93 N Pakrou (5114_CR45) 2008; 17 Y Chen (5114_CR9) 2009; 46 MC Leske (5114_CR34) 2009; 20 MPY Chan (5114_CR7) 2016; 123 L Quaranta (5114_CR46) 2013; 58 DO Kennedy (5114_CR33) 2011; 86 R Corti (5114_CR13) 2002; 106 J Rysz (5114_CR48) 2017; 23 CGV Moraes De (5114_CR17) 2011; 129 OB Ajayi (5114_CR3) 2001; 10 JJ Barone (5114_CR6) 1996; 34 N Terai (5114_CR51) 2012; 90 CF Haskell (5114_CR28) 2005; 179 ML Nurminen (5114_CR42) 1999; 53 5114_CR4 YC Tham (5114_CR52) 2014; 121 AC Cuckson (5114_CR15) 2004; 9 R Avisar (5114_CR5) 2002; 36 E Childs (5114_CR11) 2006; 185 SJL Einöther (5114_CR22) 2013; 225 G Grosso (5114_CR26) 2016; 31 S Ferré (5114_CR23) 2008; 105 |
| References_xml | – volume: 179 start-page: 813 year: 2005 end-page: 825 ident: CR28 article-title: Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine publication-title: Psychopharmacology doi: 10.1007/s00213-004-2104-3 – volume: 10 start-page: 25 year: 2001 end-page: 31 ident: CR3 article-title: Caffeine and intraocular pressure in a Nigerian population publication-title: J Glaucoma doi: 10.1097/00061198-200102000-00006 – volume: 92 start-page: 252 year: 2014 end-page: 266 ident: CR14 article-title: Ocular perfusion pressure in glaucoma publication-title: Acta Ophthalmol doi: 10.1111/aos.12298 – volume: 46 start-page: 170 year: 2002 end-page: 176 ident: CR43 article-title: Effects of caffeine on microcirculation of the human ocular fundus publication-title: Jpn J Ophthalmol doi: 10.1016/S0021-5155(01)00498-1 – volume: 58 start-page: 26 year: 2013 end-page: 41 ident: CR46 article-title: 24-hour intraocular pressure and ocular perfusion pressure in glaucoma publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2012.05.003 – ident: CR4 – volume: 49 start-page: 1924 year: 2008 end-page: 1931 ident: CR32 article-title: Caffeine consumption and the risk of primary open - angle glaucoma: a prospective cohort study publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-1425 – volume: 37 start-page: 131 year: 2017 end-page: 156 ident: CR27 article-title: Coffee, caffeine, and health outcomes: an umbrella review publication-title: Annu Rev Nutr doi: 10.1146/annurev-nutr-071816-064941 – volume: 31 start-page: 1191 year: 2016 end-page: 1205 ident: CR26 article-title: Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis publication-title: Eur J Epidemiol doi: 10.1007/s10654-016-0202-2 – volume: 9 start-page: 150 year: 1972 ident: CR29 article-title: Development and use of Stanford Sleepiness Scale (SSS) publication-title: Psychophysiology – volume: 35 start-page: 281 year: 2016 end-page: 286 ident: CR20 article-title: Acute effects of caffeine on choroidal thickness and ocular pulse amplitude publication-title: Cutan Ocul Toxicol doi: 10.3109/15569527.2015.1104330 – volume: 157 start-page: 373 year: 2001 end-page: 380 ident: CR37 article-title: Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal publication-title: Psychopharmacology doi: 10.1007/s002130100841 – volume: 20 start-page: 73 year: 2009 end-page: 78 ident: CR34 article-title: Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings publication-title: Curr Opin Ophthalmol doi: 10.1097/ICU.0b013e32831eef82 – volume: 42 start-page: 105 year: 2008 end-page: 110 ident: CR39 article-title: Timing of blood pressure measurement related to caffeine consumption publication-title: Ann Pharmacother doi: 10.1345/aph.1K337 – volume: 106 start-page: 2935 year: 2002 end-page: 2940 ident: CR13 article-title: Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content role of habitual versus nonhabitual drinking publication-title: Circulation doi: 10.1161/01.CIR.0000046228.97025.3A – volume: 105 start-page: 1067 year: 2008 end-page: 1079 ident: CR23 article-title: An update on the mechanisms of the psychostimulant effects of caffeine publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.05196.x – volume: 17 start-page: 43 year: 2008 end-page: 47 ident: CR45 article-title: Clinical comparison of the Icare tonometer and Goldmann applanation tonometry publication-title: J Glaucoma doi: 10.1097/IJG.0b013e318133fb32 – volume: 26 start-page: 932 year: 2010 end-page: 938 ident: CR25 article-title: Caffeine-not just a stimulant publication-title: Nutrition doi: 10.1016/j.nut.2010.08.004 – volume: 36 start-page: 992 year: 2002 end-page: 995 ident: CR5 article-title: Effect of coffee consumption on intraocular pressure publication-title: Ann Pharmacother doi: 10.1345/aph.1A279 – volume: 225 start-page: 251 year: 2013 end-page: 274 ident: CR22 article-title: Caffeine as an attention enhancer: reviewing existing assumptions publication-title: Psychopharmacology doi: 10.1007/s00213-012-2917-4 – volume: 86 start-page: 298 year: 2011 end-page: 306 ident: CR33 article-title: Cerebral blood flow and behavioural effects of caffeine in habitual and non-habitual consumers of caffeine: a near infrared spectroscopy study publication-title: Biol Psychol doi: 10.1016/j.biopsycho.2010.12.010 – volume: 93 start-page: 14 year: 2015 end-page: 21 ident: CR2 article-title: Circadian intraocular pressure patterns in healthy subjects , primary open angle and normal tension glaucoma patients with a contact lens sensor publication-title: Acta Ophthalmol doi: 10.1111/aos.12408 – volume: 90 start-page: 1 year: 2012 end-page: 5 ident: CR51 article-title: The effect of caffeine on retinal vessel diameter in young healthy subjects publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2012.02486.x – volume: 34 start-page: 1223 year: 2014 end-page: 1228 ident: CR54 article-title: Choroidal thickness changes after a single administration of coffee in healthy subjects publication-title: Retina doi: 10.1097/IAE.0000000000000043 – volume: 14 start-page: 504 year: 2005 end-page: 507 ident: CR8 article-title: Effects of caffeine on intraocular pressure: the blue mountains eye study publication-title: J Glaucoma doi: 10.1097/01.ijg.0000184832.08783.be – volume: 93 start-page: 141 year: 2011 end-page: 155 ident: CR49 article-title: The complex interaction between ocular perfusion pressure and ocular blood flow - relevance for glaucoma publication-title: Exp Eye Res doi: 10.1016/j.exer.2010.09.002 – volume: 31 start-page: 615 year: 2016 end-page: 619 ident: CR1 article-title: Caffeine intake is associated with pupil dilation and enhanced accommodation publication-title: Eye doi: 10.1038/eye.2016.288 – volume: 117 start-page: 1514 year: 2014 end-page: 1523 ident: CR19 article-title: Cortical substrates of the effects of caffeine and time-on-task on perception of effort publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00898.2013 – volume: 91 start-page: 171 year: 2014 end-page: 177 ident: CR44 article-title: The effect of caffeine on tear secretion publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000129 – volume: 117 start-page: 1 year: 2016 end-page: 12 ident: CR50 article-title: Effects of caffeine on neuromuscular fatigue and performance during high-intensity cycling exercise in moderate hypoxia publication-title: Eur J Appl Physiol doi: 10.1007/s00421-016-3496-6 – volume: 123 start-page: 771 year: 2016 end-page: 782 ident: CR7 article-title: Associations with intraocular pressure in a large cohort: results from the UK Biobank publication-title: Ophthalmology doi: 10.1016/j.ophtha.2015.11.031 – volume: 46 start-page: 577 year: 2009 end-page: 583 ident: CR9 article-title: Caffeine dose effect on activation-induced BOLD and CBF responses publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.03.012 – volume: 54 start-page: 400 year: 2002 end-page: 406 ident: CR55 article-title: Central and peripheral effects of sustained caffeine use: tolerance is incomplete publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.2002.01681.x – volume: 66 start-page: 19 year: 2000 end-page: 28 ident: CR47 article-title: The acute physiological and mood effects of tea and coffee publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(00)00192-1 – ident: CR53 – volume: 249 start-page: 435 year: 2011 end-page: 442 ident: CR35 article-title: The effect of caffeine on intraocular pressure: a systematic review and meta-analysis publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-010-1455-1 – volume: 34 start-page: 119 year: 1996 end-page: 129 ident: CR6 article-title: Caffeine Consumption publication-title: Fd Chem Toxic doi: 10.1016/0278-6915(95)00093-3 – volume: 234 start-page: 2311 year: 2017 end-page: 2323 ident: CR12 article-title: Caffeine increases the velocity of rapid eye movements in unfatigued humans publication-title: Psychopharmacology doi: 10.1007/s00213-017-4638-1 – volume: 13 start-page: 36 year: 2013 end-page: 42 ident: CR10 article-title: Ocular perfusion pressure and ocular blood flow in glaucoma publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.09.003 – volume: 10022 start-page: 1 year: 2018 end-page: 7 ident: CR18 article-title: Association between 24-hour intraocular pressure monitored with contact lens sensor and visual field progression in older adults with glaucoma publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2018.1746 – ident: CR40 – volume: 256 start-page: 1711 year: 2018 end-page: 1721 ident: CR30 article-title: Pulse waveform analysis on temporal changes in ocular blood flow due to caffeine intake: a comparative study between habitual and non-habitual groups publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-018-4030-9 – volume: 17 start-page: 139 year: 1992 end-page: 170 ident: CR41 article-title: Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects publication-title: Brain Res Rev doi: 10.1016/0165-0173(92)90012-B – volume: 129 start-page: 562 year: 2011 end-page: 568 ident: CR17 article-title: Risk factors for visual field progression in treated glaucoma publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2011.72 – volume: 2010 start-page: 1 year: 2010 end-page: 10 ident: CR21 article-title: Caffeine’s vascular mechanisms of action publication-title: Int J Vasc Med doi: 10.1155/2010/834060 – volume: 100 start-page: 354 year: 1999 end-page: 360 ident: CR24 article-title: Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study publication-title: Circulation doi: 10.1161/01.CIR.100.4.354 – volume: 53 start-page: 831 year: 1999 end-page: 839 ident: CR42 article-title: Coffee, caffeine and blood pressure: a critical review publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1600899 – volume: 121 start-page: 2081 year: 2014 end-page: 2090 ident: CR52 article-title: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.05.013 – volume: 26 start-page: 1122 year: 2012 end-page: 1130 ident: CR31 article-title: Effects of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude: a randomized controlled trial publication-title: Eye doi: 10.1038/eye.2012.113 – volume: 185 start-page: 514 year: 2006 end-page: 523 ident: CR11 article-title: Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users publication-title: Psychopharmacology doi: 10.1007/s00213-006-0341-3 – volume: 23 start-page: 2453 year: 2017 end-page: 2461 ident: CR48 article-title: Hypertension - current natural strategies to lower blood pressure publication-title: Curr Pharm Des doi: 10.2174/1381612823666170215144649 – volume: 178 start-page: 1086 year: 2018 end-page: 1097 ident: CR36 article-title: Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2018.2425 – volume: 9 start-page: 31 year: 2004 end-page: 37 ident: CR15 article-title: Clinical evaluation of an automated oscillometric blood pressure wrist device publication-title: Blood Press Monit doi: 10.1097/00126097-200402000-00007 – volume: 0 start-page: 1 year: 2017 end-page: 10 ident: CR16 article-title: Coffee consumption and risk of hypertension: a dose–response meta-analysis of prospective studies publication-title: Eur J Nutr doi: 10.1007/s00394-017-1591-z – volume: 311 start-page: 795 year: 1978 end-page: 797 ident: CR38 article-title: Circadian variation of blood-pressure publication-title: Lancet doi: 10.1016/S0140-6736(78)92998-7 – volume: 105 start-page: 1067 year: 2008 ident: 5114_CR23 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.05196.x – volume: 34 start-page: 1223 year: 2014 ident: 5114_CR54 publication-title: Retina doi: 10.1097/IAE.0000000000000043 – volume: 225 start-page: 251 year: 2013 ident: 5114_CR22 publication-title: Psychopharmacology doi: 10.1007/s00213-012-2917-4 – volume: 91 start-page: 171 year: 2014 ident: 5114_CR44 publication-title: Optom Vis Sci doi: 10.1097/OPX.0000000000000129 – volume: 93 start-page: 14 year: 2015 ident: 5114_CR2 publication-title: Acta Ophthalmol doi: 10.1111/aos.12408 – volume: 10 start-page: 25 year: 2001 ident: 5114_CR3 publication-title: J Glaucoma doi: 10.1097/00061198-200102000-00006 – volume: 34 start-page: 119 year: 1996 ident: 5114_CR6 publication-title: Fd Chem Toxic doi: 10.1016/0278-6915(95)00093-3 – volume: 185 start-page: 514 year: 2006 ident: 5114_CR11 publication-title: Psychopharmacology doi: 10.1007/s00213-006-0341-3 – volume: 10022 start-page: 1 year: 2018 ident: 5114_CR18 publication-title: JAMA Ophthalmol doi: 10.1001/jamaophthalmol.2018.1746 – volume: 42 start-page: 105 year: 2008 ident: 5114_CR39 publication-title: Ann Pharmacother doi: 10.1345/aph.1K337 – volume: 54 start-page: 400 year: 2002 ident: 5114_CR55 publication-title: Br J Clin Pharmacol doi: 10.1046/j.1365-2125.2002.01681.x – volume: 100 start-page: 354 year: 1999 ident: 5114_CR24 publication-title: Circulation doi: 10.1161/01.CIR.100.4.354 – volume: 178 start-page: 1086 year: 2018 ident: 5114_CR36 publication-title: JAMA Intern Med doi: 10.1001/jamainternmed.2018.2425 – volume: 23 start-page: 2453 year: 2017 ident: 5114_CR48 publication-title: Curr Pharm Des doi: 10.2174/1381612823666170215144649 – volume: 20 start-page: 73 year: 2009 ident: 5114_CR34 publication-title: Curr Opin Ophthalmol doi: 10.1097/ICU.0b013e32831eef82 – volume: 9 start-page: 31 year: 2004 ident: 5114_CR15 publication-title: Blood Press Monit doi: 10.1097/00126097-200402000-00007 – volume: 31 start-page: 1191 year: 2016 ident: 5114_CR26 publication-title: Eur J Epidemiol doi: 10.1007/s10654-016-0202-2 – volume: 17 start-page: 43 year: 2008 ident: 5114_CR45 publication-title: J Glaucoma doi: 10.1097/IJG.0b013e318133fb32 – volume: 66 start-page: 19 year: 2000 ident: 5114_CR47 publication-title: Pharmacol Biochem Behav doi: 10.1016/S0091-3057(00)00192-1 – volume: 93 start-page: 141 year: 2011 ident: 5114_CR49 publication-title: Exp Eye Res doi: 10.1016/j.exer.2010.09.002 – volume: 58 start-page: 26 year: 2013 ident: 5114_CR46 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2012.05.003 – volume: 117 start-page: 1514 year: 2014 ident: 5114_CR19 publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00898.2013 – volume: 13 start-page: 36 year: 2013 ident: 5114_CR10 publication-title: Curr Opin Pharmacol doi: 10.1016/j.coph.2012.09.003 – volume: 14 start-page: 504 year: 2005 ident: 5114_CR8 publication-title: J Glaucoma doi: 10.1097/01.ijg.0000184832.08783.be – volume: 234 start-page: 2311 year: 2017 ident: 5114_CR12 publication-title: Psychopharmacology doi: 10.1007/s00213-017-4638-1 – volume: 46 start-page: 577 year: 2009 ident: 5114_CR9 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2009.03.012 – volume: 311 start-page: 795 year: 1978 ident: 5114_CR38 publication-title: Lancet doi: 10.1016/S0140-6736(78)92998-7 – volume: 31 start-page: 615 year: 2016 ident: 5114_CR1 publication-title: Eye doi: 10.1038/eye.2016.288 – volume: 106 start-page: 2935 year: 2002 ident: 5114_CR13 publication-title: Circulation doi: 10.1161/01.CIR.0000046228.97025.3A – volume: 37 start-page: 131 year: 2017 ident: 5114_CR27 publication-title: Annu Rev Nutr doi: 10.1146/annurev-nutr-071816-064941 – volume: 53 start-page: 831 year: 1999 ident: 5114_CR42 publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1600899 – volume: 121 start-page: 2081 year: 2014 ident: 5114_CR52 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2014.05.013 – volume: 123 start-page: 771 year: 2016 ident: 5114_CR7 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2015.11.031 – volume: 92 start-page: 252 year: 2014 ident: 5114_CR14 publication-title: Acta Ophthalmol doi: 10.1111/aos.12298 – volume: 249 start-page: 435 year: 2011 ident: 5114_CR35 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-010-1455-1 – volume: 2010 start-page: 1 year: 2010 ident: 5114_CR21 publication-title: Int J Vasc Med doi: 10.1155/2010/834060 – volume: 256 start-page: 1711 year: 2018 ident: 5114_CR30 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-018-4030-9 – volume: 26 start-page: 932 year: 2010 ident: 5114_CR25 publication-title: Nutrition doi: 10.1016/j.nut.2010.08.004 – volume: 9 start-page: 150 year: 1972 ident: 5114_CR29 publication-title: Psychophysiology – ident: 5114_CR40 – volume: 26 start-page: 1122 year: 2012 ident: 5114_CR31 publication-title: Eye doi: 10.1038/eye.2012.113 – volume: 0 start-page: 1 year: 2017 ident: 5114_CR16 publication-title: Eur J Nutr doi: 10.1007/s00394-017-1591-z – volume: 117 start-page: 1 year: 2016 ident: 5114_CR50 publication-title: Eur J Appl Physiol doi: 10.1007/s00421-016-3496-6 – volume: 36 start-page: 992 year: 2002 ident: 5114_CR5 publication-title: Ann Pharmacother doi: 10.1345/aph.1A279 – ident: 5114_CR4 doi: 10.1111/opo.12009 – volume: 46 start-page: 170 year: 2002 ident: 5114_CR43 publication-title: Jpn J Ophthalmol doi: 10.1016/S0021-5155(01)00498-1 – volume: 157 start-page: 373 year: 2001 ident: 5114_CR37 publication-title: Psychopharmacology doi: 10.1007/s002130100841 – ident: 5114_CR53 doi: 10.1016/j.ophtha.2005.01.042 – volume: 86 start-page: 298 year: 2011 ident: 5114_CR33 publication-title: Biol Psychol doi: 10.1016/j.biopsycho.2010.12.010 – volume: 17 start-page: 139 year: 1992 ident: 5114_CR41 publication-title: Brain Res Rev doi: 10.1016/0165-0173(92)90012-B – volume: 35 start-page: 281 year: 2016 ident: 5114_CR20 publication-title: Cutan Ocul Toxicol doi: 10.3109/15569527.2015.1104330 – volume: 49 start-page: 1924 year: 2008 ident: 5114_CR32 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.07-1425 – volume: 129 start-page: 562 year: 2011 ident: 5114_CR17 publication-title: Arch Ophthalmol doi: 10.1001/archophthalmol.2011.72 – volume: 90 start-page: 1 year: 2012 ident: 5114_CR51 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2012.02486.x – volume: 179 start-page: 813 year: 2005 ident: 5114_CR28 publication-title: Psychopharmacology doi: 10.1007/s00213-004-2104-3 |
| SSID | ssj0000484 ssj0068394 |
| Score | 2.439705 |
| Snippet | Background
Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between... Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between low- and... Background Caffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between... BackgroundCaffeine has a well-established effect on intraocular pressure (IOP) and ocular perfusion pressure (OPP); however, the possible differences between... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 811 |
| SubjectTerms | Adenosine Adolescent Adult Arousal Biomedical and Life Sciences Biomedicine Caffeine Caffeine - administration & dosage Coffee (Beverage) Comparative literature Comparative studies Consumer behavior Consumer research Consumers Consumption Cross-Over Studies Double-Blind Method Drug Tolerance - physiology Female Future predictions Glaucoma Humans Intraocular pressure Intraocular Pressure - drug effects Intraocular Pressure - physiology Male Medical research Neurosciences Observations Original Investigation Perfusion Pharmacology/Toxicology Physiological aspects Pressure Psychiatry Purines Tonometry, Ocular - methods Young Adult |
| SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBelhbKXsXVf3tpxg9HBVoNtyYrTtzBWyqClDw30TejLMAj2qBNGH_ef706W7aZ0g0ECMT7JCqfT_eS7-4mxj8Lb3M98nfq5qVLhMk8mJVPneF1ZdHAu8GxfXMrzpfh-U97EOu5uyHYfQpJhpR6L3cgdUe5PlSJIECmuu3slbd1xEi-LxbT8Cqq87C8kuv-eh5lTFVlZDXHNx_rb8kwP1-d7DupBxDQ4orNn7GlEkLDoVf6c7fjmgO1fxBj5ATu-6tmo707geiqu6k7gGK4mnuq7F-x3z1zcQVuD1fgbm0PbwA9639uG_FQIabKbWw8av93G0FsbWLf4WXk6ksOfggY7MYhDoKuFmP0Fq_YX6MYBkSJPz7Cx7LN7yZZn366_nqfxRIbUInBZpx7NX8qi5oZXuLEsnZAC_ftsbqSZCe2FNA4BUuEKJ70phREI0Oq61BT8lMLxV2y3aRv_hkFu8yoTWmpBpXau0Cg_47mxlZxLl_GEZYM2lI105XRqxkqNRMtBgQoVqEiBqkjY57HJz56r41_Cn0jFiuwY-7U6liPg6IgRSy1K3HdIzmWesMMtSbQ_u317mCQq2n-n8Fm41UPwKBL2YbxNLSmnrfHtJsgUxNdYlQl73U-ucdg8E4gsOY7yyzDbps7_-p_e_pf0O_YE0d-8T0E_ZLvr240_QoS1Nu-DRf0BsusYxg priority: 102 providerName: Springer Nature |
| Title | Effects of caffeine on intraocular pressure are subject to tolerance: a comparative study between low and high caffeine consumers |
| URI | https://link.springer.com/article/10.1007/s00213-018-5114-2 https://www.ncbi.nlm.nih.gov/pubmed/30417232 https://www.proquest.com/docview/2131741254 https://www.proquest.com/docview/2132249285 |
| Volume | 236 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdbC2MvY-u-3HZFg9HBVlNbkmVnLyPZkpWNljAayJ6MvgyDYHd1wujj_vPdyUq8FFZIcIIkR-Gku591d78j5I1wJnW5q2I30EUsbOJwS8nYWl4VBgyc9Tzb5xfybCa-zrN5OHBrQ1jlWid6RW0bg2fkpywFSyfAHIuPV79irBqF3tVQQuM-2UXqMgzpyud5r4kFJmF2XyQggY6SmWNCWVasXZyJZxRlWOQgLWLAHyJmW0bqtqr-x1bdcp56mzR5TB4FMEmHnfSfkHuu3iMPzoO7fI8cTzti6psTetnnWbUn9JhOe8rqm6fkT0di3NKmokbBZxhOm5r-xKPfxoeqUh8xu7p2VMG7XWk8wKHLBl4Lh9U53AeqqOnJxKlnrqUhEIwumt9U1ZYiP3L_GyZkgLbPyGwyvvx0FofiDLEBDLOMHWgCKVnFNS_gGTOzQgow9flAS50L5YTUFrASs8xKpzOhBWC1qsoU-kGlsPw52amb2r0kNDVpkQgllcCsO8sU9M95qk0hB9ImPCLJWhqlCczlWEBjUW44l70ASxBgiQIsWUTebYZcdbQdd3V-iyIucUvDfY0KmQkwOyTHKocZPIJIzmUakcOtnrAVzXbzepGUQRW0Zb9wI_J604wjMbytds3K92FI3VhkEXnRLa7NtHkiAGRymOX79Wrrb_7f_7R_91QOyENAfoMu_PyQ7CyvV-4VoKulPvJb6IjsDkefRxO8fvnxbQzX0fhi-h1aZ2z4F1hDIdQ |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxNBEB9qCuqLaP06rbqCVtAe3u3ubS6CSNWW1DYhSAp9O_d290AId7WXUPLoP-Tf6Mx95EzBvhUSSLjdzYb53J2Z3wC8ks6Eru8y3w3S2Jc2cCRSyrdWZLFBA2crnO3RWA1P5LfT6HQD_rS1MJRW2erESlHbwtAd-XseoqWTaI7lp7NfPnWNouhq20KjZosjt7zAI1v58fAr0vc15wf70y9Dv-kq4Bs0vnPfIQsrxTORihgPR5GVSqKN6g9SlfaldlKlFo08t9wql0YylehkZFmkKYCnpBW47g3YlAKPMj3Y_Lw_nnzvdL-kss_6i0LfowaBFlTCFsVtUDWoMEw5tVUIYx89HunzNbN42Tj8Yx0vhWsrK3hwF-407ivbq_ntHmy4fAtujpoA_RbsTGoo7OUum3aVXeUu22GTDiR7eR9-17DJJSsyZjR-xumsyNlPumwuquRYVuXoLs4d0_guFyldGbF5ga-Zo34g7gPTzHTw5azCymVN6hmbFRdM55YRInP3G6apOS0fwMm1EO4h9PIid4-BhSaMA6mVllTnZ7nG8X0RpiZWA2UD4UHQUiMxDVY6teyYJSuU54qACRIwIQIm3IO3qylnNVDIVYPfEIkTUiK4rtFNLQTujuC4kr0IDz1KCBV6sL02EoXfrD9umSRplE-ZdKLiwcvVY5pJCXW5KxbVGE5gkXHkwaOauVbbFoFEt1bgLt-13NYt_t__9OTqrbyAW8Pp6Dg5PhwfPYXb6HcO6uT3bejNzxfuGfp28_R5I1AMfly3DP8FM_NYlg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxNBEB9qheKLaP2KVl1BK2iP3u3u7V0EkWINrbUlDy3k7bpfB0K4q72Ekkf_Lf86Z-4jZwr2rZBAwu1uNszM_mZ3Z34D8FZ6G_nE54EfmjSQLvRkUipwTuSpRYBzNc_28Yk6OJPfJ_FkDf50uTAUVtmtifVC7UpLZ-S7PEKkkwjHcjdvwyLG-6MvF78CqiBFN61dOY1GRY784gq3b9Xnw32U9TvOR99Ovx4EbYWBwCIQzwKP6qwUz4URKW6UYieVRLxKhkaZRGovlXEI-Nxxp7yJpZHocOR5rOkyT0kncNw7cDcRcUQ2lkySHgUkJYA2XxR6IQ0dtKBktjjtrlfDms2UU4GFKA3Q95EBXwHI6zDxD05eu7it8XD0AO63jizbazTvIaz5YhM2jtur-k3YHjek2IsddtrneFU7bJuNe7rsxSP43RAoV6zMmdX4GbuzsmA_6di5rMNkWR2tO7_0TOO7mhs6PGKzEl9TT5VB_Cemme2JzFnNmsvaIDQ2La-YLhwjbub-N2ybfVo9hrNbEdsTWC_Kwj8DFtkoDaVWWlLGn-Ma2yciMjZVQ-VCMYCwk0ZmW9Z0Kt4xzZZ8z7UAMxRgRgLM-AA-LLtcNJQhNzV-TyLOaDnBca1usyJwdkTMle3FuP1RQqhoAFsrLXEZsKuPOyXJ2mWoynqjGcCb5WPqSaF1hS_ndRtOtJFpPICnjXItpy1CiQ6uwFl-7LStH_y__-n5zVN5DRtoudmPw5OjF3APHdBhEwW_Beuzy7l_iU7ezLyqrYnB-W2b71_PyVtm |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+caffeine+on+intraocular+pressure+are+subject+to+tolerance%3A+a+comparative+study+between+low+and+high+caffeine+consumers&rft.jtitle=Psychopharmacology+%28Berlin%2C+Germany%29&rft.au=Vera%2C+Jes%C3%BAs&rft.au=Redondo%2C+Beatr%C3%ADz&rft.au=Molina%2C+Rub%C3%A9n&rft.au=Berm%C3%BAdez%2C+Javier&rft.date=2019-02-01&rft.eissn=1432-2072&rft.volume=236&rft.issue=2&rft.spage=811&rft_id=info:doi/10.1007%2Fs00213-018-5114-2&rft_id=info%3Apmid%2F30417232&rft.externalDocID=30417232 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |